Ointment for Topical Ocular Delivery of Voriconazole: Formulation Development, In‐Vitro Characterization & In‐Vivo Pharmacokinetic Assessment
: 32.60 ± 26.64 μg/mL), indicating approximately 12-fold enhanced retention. These findings suggest that the optimized ointment is a promising option for effective and prolonged ocular delivery of VCZ in the treatment of FK.
Authors
- Rabi Sankar Bhatta (ORCID: https://orcid.org/0000-0003-4844-2388)
- Sachin Nashik Sanap (ORCID: https://orcid.org/0000-0002-1427-9247)
- Sristi Agrawal (ORCID: https://orcid.org/0009-0008-4656-131X)
- Amol Chhatrapati Bisen (ORCID: https://orcid.org/0000-0003-4841-0140)
- Ayush Dubey (ORCID: https://orcid.org/0009-0003-5477-4300)
- Arpon Biswas (ORCID: https://orcid.org/0000-0002-3755-407X)
Institutions
- Central Drug Research Institute (IN)
- National Institute of Nutrition (IN)
- Academy of Scientific and Innovative Research (IN)
Publication Details
- Journal
- Biopharmaceutics & Drug Disposition
- Published
- 2026-04-16
- DOI
- https://doi.org/10.1002/bdd.70029
- Citations
- 1
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 14.92